1. 11 years' follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive early breast cancer: final analysis of the HERceptin Adjuvant (HERA) trial. Issue 10075 (25th March 2017) Authors: Cameron, David; Piccart-Gebhart, Martine J; Gelber, Richard D; Procter, Marion; Goldhirsch, Aron; de Azambuja, Evandro; Castro, Gilberto; Untch, Michael; Smith, Ian; Gianni, Luca; Baselga, Jose; Al-Sakaff, Nedal; Lauer, Sabine; McFadden, Eleanor; Leyland-Jones, Brian; Bell, Richard; Dowsett, Mitc... Journal: Lancet Issue: Volume 389:Issue 10075(2017) Page Start: 1195 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Adjuvant Pertuzumab and Trastuzumab in Early HER2-Positive Breast Cancer in the APHINITY Trial: 6 Years' Follow-Up. Issue 13 (1st May 2021) Authors: Piccart, Martine; Procter, Marion; Fumagalli, Debora; de Azambuja, Evandro; Clark, Emma; Ewer, Michael S.; Restuccia, Eleonora; Jerusalem, Guy; Dent, Susan; Reaby, Linda; Bonnefoi, Hervé; Krop, Ian; Liu, Tsang-Wu; Pieńkowski, Tadeusz; Toi, Masakazu; Wilcken, Nicholas; Andersson, Michael; Im, Youn... Journal: Journal of clinical oncology Issue: Volume 39:Issue 13(2021) Page Start: 1448 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Concerns about cardiotoxicity in the HERA trial – Authors' reply. Issue 10114 (23rd December 2017) Authors: Cameron, David A; Gelber, Richard D; Procter, Marion; Suter, Thomas Journal: Lancet Issue: Volume 390:Issue 10114(2017) Page Start: 2767 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Imputing missing quality of life data as covariate in survival analysis of the International Breast Cancer Study Group Trials VI and VII. Issue 2 (7th February 2019) Authors: Procter, Marion; Robertson, Chris Journal: Communications in statistics Issue: Volume 48:Issue 2(2019) Page Start: 580 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Simulation Study to Estimate Bias of Treatment Effect in Pain Scores in Diabetic Neuropathy. Issue 5 (24th August 2019) Authors: Procter, Marion Journal: Pain medicine Issue: Volume 21:Issue 5(2020) Page Start: 1081 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Six-year absolute invasive disease-free survival benefit of adding adjuvant pertuzumab to trastuzumab and chemotherapy for patients with early HER2-positive breast cancer: A Subpopulation Treatment Effect Pattern Plot (STEPP) analysis of the APHINITY (BIG 4-11) trial. (May 2022) Authors: Gelber, Richard D.; Wang, Xin V.; Cole, Bernard F.; Cameron, David; Cardoso, Fatima; Tjan-Heijnen, Vivianne; Krop, Ian; Loi, Sherene; Salgado, Roberto; Kiermaier, Astrid; Frank, Elizabeth; Fumagalli, Debora; Caballero, Carmela; de Azambuja, Evandro; Procter, Marion; Clark, Emma; Restuccia, Eleono... Journal: European journal of cancer Issue: Volume 166(2022) Page Start: 219 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗